Cleft lip and palate

The Lancet

Volumn 374, Issue 9703, 2009, Pages 1773-1785

  Mossey, Peter A ^a   Little, Julian ^b   Munger, Ron G ^c   Dixon, Mike J ^d   Shaw, William C ^d  

^a DUNDEE DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UTAH STATE UNIVERSITY   (United States)

^d UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD DEVELOPMENT; CLEFT LIP PALATE; COST OF ILLNESS; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; EUROPE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INTEGRATION; LIFESTYLE; MATERNAL NUTRITION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; VITAMIN INTAKE;

EID: 70449629175     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60695-4     Document Type: Review

References (172)

1. Ngai C.W., Martin W.L., Tonks A., Wyldes M.P., and Kilby M.D. Are isolated facial cleft lip and palate associated with increased perinatal mortality? A cohort study from the West Midlands Region, 1995-1997. J Matern Fetal Neonatal Med 17 (2005) 203-206
2. Christensen K., Juel K., Herskind A.M., and Murray J.C. Long term follow up study of survival associated with cleft lip and palate at birth. BMJ 328 (2004) 1405
3. Nopoulos P., Langbehn D.R., Canady J., Magnotta V., and Richman L. Abnormal brain structure in children with isolated clefts of the lip or palate. Arch Pediatr Adolesc Med 161 (2007) 753-758
4. Berk N.W., and Marazita M.L. The costs of cleft lip and palate: personal and societal implications. In: Wyszynski D.F. (Ed). Cleft lip and palate: from origin to treatment (2002), Oxford University Press, New York 458-467
5. WHO Human Genetics Programme. Global strategies to reduce the health-care burden of craniofacial anomalies: report of WHO meetings on international collaborative research on craniofacial anomalies (2002), World Health Organization, Geneva
6. Sperber G.H. Formation of the primary and secondary palate. In: Wyszynski D.F. (Ed). Cleft lip and palate: from origin to treatment (2002), Oxford University Press, New York 5-24
7. Neilson D.E., Brunger J.W., Heeger S., Bamshad M., and Robin N.H. Mixed clefting type in Rapp-Hodgkin syndrome. Am J Med Genet 108 (2002) 281-284
8. Jiang R., Bush J.O., and Lidral A.C. Development of the upper lip: morphogenetic and molecular mechanisms. Dev Dyn 235 (2006) 1152-1166
9. Barlow A.J., Bogardi J.P., Ladher R., and Francis-West P.H. Expression of chick Barx-1 and its differential regulation by FGF-8 and BMP signaling in the maxillary primordia. Dev Dyn 214 (1999) 291-302
10. Lee S.H., Fu K.K., Hui J.N., and Richman J.M. Noggin and retinoic acid transform the identity of avian facial prominences. Nature 414 (2001) 909-912
11. Ashique A.M., Fu K., and Richman J.M. Endogenous bone morphogenetic proteins regulate outgrowth and epithelial survival during avian lip fusion. Development 129 (2002) 4647-4660
12. Hu D., Marcucio R.S., and Helms J.A. A zone of frontonasal ectoderm regulates patterning and growth in the face. Development 130 (2003) 1749-1758
13. Sun D., Baur S., and Hay E.D. Epithelial-mesenchymal transformation is the mechanism for fusion of the craniofacial primordia involved in morphogenesis of the chicken lip. Dev Biol 228 (2000) 337-349
14. Thomason H.A., Dixon M.J., and Dixon J. Facial clefting in Tp63 deficient mice results from altered Bmp4, Fgf8 and Shh signaling. Dev Biol 321 (2008) 273-282
15. Gritli-Linde A. Molecular control of secondary palate development. Dev Biol 301 (2007) 309-326
16. Ito Y., Yeo J.Y., Chytil A., et al. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130 (2003) 5269-5280
17. Rice R., Spencer-Dene B., Connor E.C., et al. Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 113 (2004) 1692-1700
18. Zhang Z., Song Y., Zhao X., Zhang X., Fermin C., and Chen Y. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129 (2002) 4135-4146
19. van den Boogaard M.J., Dorland M., Beemer F.A., and van Amstel H.K. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 24 (2000) 342-343
20. Casey L.M., Lan Y., Cho E.-S., Maltby K.M., Gridley T., and Jiang R. Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. Dev Dyn 235 (2006) 1830-1844
21. Kondo S., Schutte B.C., Richardson R.J., et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32 (2002) 285-289
22. Ingraham C.R., Kinoshita A., Kondo S., et al. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 38 (2006) 1335-1340
23. Richardson R.J., Dixon J., Malhotra S., et al. IRF6 is a key determinant of the keratinocyte proliferation/differentiation switch. Nat Genet 38 (2006) 1329-1334
24. Suzuki K., Hu D., Bustos T., et al. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat Genet 25 (2000) 427-430
25. Mogass M., Bringas Jr. P., and Shuler C.F. Characterization of desmosomal component expression during palatogenesis. Int J Dev Biol 44 (2000) 317-322
26. Miettinen P.J., Chin J.R., Shum L., et al. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22 (1999) 69-73
27. Fitzpatrick D.R., Denhez F., Kondaiah P., and Akhurst R.J. Differential expression of TGF beta isoforms in murine palatogenesis. Development 109 (1990) 585-595
28. Proetzel G., Pawlowski S.A., Wiles M.V., et al. Transforming growth factor-β3 is required for secondary palate fusion. Nat Genet 11 (1995) 409-414
29. Kaartinen V., Cui X.M., Heisterkamp N., Groffen J., and Shuler C.F. Transforming growth factor-β3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associate degradation of the basement membrane. Dev Dyn 209 (1997) 255-260
30. Taya Y., O'Kane S., and Ferguson M.W.J. Pathogenesis of cleft palate in TGF-β3 knockout mice. Development 126 (1999) 3869-3879
31. Gato A., Martinez M.L., Tudela C., et al. TGF-β3-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev Biol 250 (2002) 393-405
32. Martinez-Alvares C., Bonelli R., Tudela C., et al. Bulging medial edge epithelial cells and palatal fusion. Int J Dev Biol 44 (2000) 331-335
33. Tudela C., Formoso M.-A., Martinez T., et al. TGF-β3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion. Int J Dev Biol 46 (2002) 333-336
34. Blavier L., Lazaryev A.L., Groffen J., Heisterkamp N., DeClerk Y.A., and Kaartinen V. Tgf-β3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell 12 (2001) 1457-1466
35. Knight A.S., Schutte B.C., Jiang R., and Dixon M.J. Developmental expression analysis of the mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome. Dev Dyn 235 (2006) 1441-1447
36. Xu X., Han J., Ito Y., Bringas Jr. P., Urata M.M., and Chai Y. Cell autonomous requirement for Tgfbr2 in the disappearance of the medial edge epithelium during palatal fusion. Dev Biol 297 (2006) 238-248
37. Cuervo R., Valencia C., Chandraratna R.A., and Covarrubias L. Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid. Dev Biol 245 (2002) 145-156
38. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., and Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94 (1998) 727-737
39. Cuervo R., and Covarrubias L. Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis. Development 131 (2004) 15-24
40. Mossey P.A., and Little J. Epidemiology of oral clefts: an international perspective. In: Wyszynski D.F. (Ed). Cleft lip and palate: from origins to treatment (2002), Oxford University Press, New York 127-158
41. Mossey P., and Castillia E. Global registry and database on craniofacial anomalies (2003), World Health Organization, Geneva
42. Croen L.A., Shaw G.M., Wasserman C.R., et al. Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet 79 (1998) 42-47
43. Leck I., and Lancashire R.J. Birth prevalence of malformations in members of different ethnic groups and in the offspring of matings between them in Birmingham, England. J Epidemiol Community Health 49 (1995) 171-179
44. Ching G.H., and Chung C.S. A genetic study of cleft lip and palate in Hawaii: I-interracial crosses. Am J Hum Genet 26 (1974) 162-176
45. International Clearinghouse for Birth Defects Monitoring Systems. Annual report 2001 (with data for 1999) (2001), ICBDMS, Rome
46. Castilla E.E., Orioli I.M., Lugarinho R., et al. Monthly and seasonal variations in the frequency of congenital anomalies. Int J Epidemiol 19 (1990) 399-404
47. Fraser F.C., and Gwyn A. Seasonal variation in birth date of children with cleft lip. Teratology 57 (1998) 93-95
48. Fujino H., Tanaka K., Sanui Y., et al. Genetic studies of cleft lips and cleft palate based on 2828 Japanese cases. Kyushu J Med Sci 14 (1963) 317-331
49. Fogh-Andersen P. Inheritance of harelip and cleft palate (1942), Munksgaard, Copenhagen
50. Niswander J.D., MacLean C.J., Chung C.S., and Dronamraju K. Sex ratio and cleft lip with or without cleft palate. Lancet 2 (1972) 858-860
51. Rittler M., Lopez-Camelo J., and Castilla E.E. Sex ratio and associated risk factors for 50 congenital anomaly types: clues for causal heterogeneity. Birth Defects Res A Clin Mol Teratol 70 (2004) 13-19
52. Calzolari E., Bianchi F., Rubini M., Ritvanen A., Neville A.J., and EUROCAT working group. Epidemiology of cleft palate in Europe: implications for genetic research. Cleft Palate Craniofac J 41 (2004) 244-249
53. Calzolari E., Pierini A., Astolfi G., Bianchi F., Neville A.J., and Rivieri F. Associated anomalies in multi-malformed infants with cleft lip and palate: an epidemiological study of nearly 6 million births in 23 EUROCAT registries. Am J Med Genet A 143 (2007) 528-537
54. Tolarova M.M., and Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet 75 (1998) 126-137
55. Clark J.D., Mossey P.A., Sharp L., et al. Socio-economic status and orofacial clefts in Scotland, 1989 to 1998. Cleft Palate Craniofac J 40 (2003) 481-485
56. Mossey P.A., Davies J.A., and Little J. Prevention of orofacial clefts: does pregnancy planning have a role?. Cleft Palate Craniofac J 44 (2007) 244-250
57. Chen X.K., Wen S.W., Fleming N., Yang Q., and Walker M.C. Teenage pregnancy and congenital anomalies: which system is vulnerable?. Hum Reprod 22 (2007) 1730-1735
58. Little J., Cardy A., and Munger R.G. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ 82 (2004) 213-218
59. Honein M.A., Rasmussen S.A., Reefhuis J., et al. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 18 (2007) 226-233
60. Romitti P., Lidral A., Munger R., et al. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts. Teratology 59 (1999) 39-50
61. Chevrier C., Perret C., Bahuau M., et al. Interaction between the ADH1C polymorphism and maternal alcohol intake in the risk of nonsyndromic oral clefts: an evaluation of the contribution of child and maternal genotypes. Birth Defects Res A Clin Mol Teratol 73 (2005) 114-122
62. Bille C., Olsen J., Vach W., et al. Oral clefts and life style factors: a case cohort study based on prospective Danish data. Eur J Epidemiol 22 (2007) 173-181
63. Meyer K.A., Werler M.M., Hayes C., et al. Low maternal alcohol consumption during pregnancy and oral clefts in offspring: the Slone Birth Defects Study. Birth Defects Res A Clin Mol Teratol 67 (2003) 509-514
64. Romitti P.A., Sun L., Honein M.A., et al. Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol 166 (2007) 775-785
65. Carmichael S.L., Shaw G.M., Yang W., Abrams B., and Lammer E.J. Maternal stressful life events and risks of birth defects. Epidemiology 18 (2007) 356-361
66. Johnson C.Y., and Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging?. Int J Epidemiol 37 (2008) 1041-1058
67. Botto L.D., Erickson J.D., Mulinare J., Lynberg M.C., and Liu Y. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction?. Epidemiology 13 (2002) 485-488
68. Douglas B. The role of environmental factors in the etiology of "so-called" congenital malformations: I-deductions from the presence of cleft lip and palate in one of identical twins, from embryology and from animal experiments. Plast Reconstr Surg 22 (1958) 94-108
69. Briggs R.M. Vitamin supplementation as a possible factor in the incidence of cleft lip/palate deformities in humans. Clin Plast Surg 3 (1976) 647-652
70. Czeizel A.E. Controlled studies of multivitamin supplementation on pregnancy outcomes. Ann N Y Acad Sci 678 (1993) 266-275
71. Ulrich M., Kristoffersen K., Rolschau J., Grinsted P., Schaumburg E., and Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark, part II: congenital anomalies-a randomised study. Eur J Obstet Gynecol Reprod Biol 87 (1999) 111-113
72. Asling C.W., Nelson M.M., Dougherty H.D., Wright H.V., and Evans H.M. The development of cleft palate resulting from maternal pteroylglutamic (folic) acid deficiency during the latter half of gestation in rats. Surg Gynecol Obstet 111 (1960) 19-28
73. Hernández-Diaz S., Werler M.M., Walker A.M., and Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343 (2000) 1608-1614
74. Simmons C.J., Mosley B.S., Fulton-Bond C.A., and Hobbs C.A. Birth defects in Arkansas: is folic acid fortification making a difference?. Birth Defects Res A Clin Mol Teratol 70 (2004) 559-564
75. Canfield M.A., Collins J.S., Botto L.D., et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73 (2005) 679-689
76. Botto L.D., Lisi A., Bower C., et al. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 76 (2006) 693-705
77. Yazdy M.M., Honein M.A., and Xing J. Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. Birth Defects Res A Clin Mol Teratol 79 (2007) 16-23
78. Ray J.G., Meier C., Vermeulen M.J., Wyatt P.R., and Cole D.E. Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 143 (2003) 805-807
79. López-Camelo J.S., Orioli I.M., da Graça Dutra M., et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 135 (2005) 120-125
80. Hill L., Murphy M., McDowall M., and Paul A.H. Maternal drug histories and congenital malformations: limb reduction defects and oral clefts. J Epidemiol Community Health 42 (1988) 1-7
81. Shaw G.M., Lammer E.J., Wasserman C.R., O'Malley C.D., and Tolarova M.M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346 (1995) 393-396
82. Czeizel A.E., Timar L., Sarkozi A., et al. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 104 (1999) e66
83. Kallen B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 40 (2003) 624-628
84. van Rooij I.A., Ocke M.C., Straatman H., et al. Periconceptional folate intake by supplement and food reduces the risk of nonsyndromic cleft lip with or without cleft palate. Prev Med 39 (2004) 689-694
85. Badovinac R.L., Werler M.M., Williams P.L., Kelsey K.T., and Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 79 (2007) 8-15
86. Little J., Gilmour M., Mossey P.A., et al. Folate and clefts of the lip and palate: a U.K.-based case-control study, part I-dietary and supplemental folate. Cleft Palate Craniofac J 45 (2008) 420-427
87. Wong W.Y., Eskes T., Kuijpers-Jagtman A.M., et al. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 60 (1999) 253-257
88. van Rooij I.A., Vermeij-Keers C., Kluijtmans L.A., et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate?. Am J Epidemiol 157 (2003) 583-591
89. Munger R.G., Sauberlich H.E., Corcoran C., Nepomuceno B., Daack-Hirsch S., and Solon F.S. Maternal vitamin B-6 and folate status and risk of oral cleft birth defects in the Philippines. Birth Defects Res A Clin Mol Teratol 70 (2004) 464-471
90. Little J., Gilmour M., Mossey P.A., et al. Folate and clefts of the lip and palate: a U.K.-based case-control study, part II-biochemical and genetic analysis. Cleft Palate Craniofac J 45 (2008) 428-438
91. Miller T.J. Cleft palate formation: a role for pyridoxine in the closure of the secondary palate in mice. Teratology 6 (1972) 351-356
92. Warkany J., and Petering H.G. Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency. Teratology 5 (1972) 319-334
93. Krapels I., van Rooij I., Wevers R.A., et al. Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: a case-control study. BJOG 111 (2004) 661-668
94. Tamura T., Munger R.G., Corcoran C., et al. Plasma zinc concentrations of mothers and the risk of nonsyndromic oral clefts in their children in the Philippines. Birth Defects Res A Clin Mol Teratol 73 (2005) 612-616
95. Warkany J., and Nelson R.S. Appearance of skeletal abnormalities in the offspring of rats reared on a deficient diet. Science 92 (1940) 383-384
96. Rothman K.J., Moore L.L., Singer M.R., et al. Teratogenicity of high vitamin A intake. N Engl J Med 333 (1995) 1369-1373
97. Mitchell L.E., Murray J.C., O'Brien S., and Christensen K. Retinoic acid receptor alpha gene variants, multivitamin use, and liver intake as risk factors for oral clefts: a population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 158 (2003) 69-76
98. Lammer E.J., Chen D.T., Hoar R.M., et al. Retinoic acid embropathy. N Engl J Med 313 (1985) 837-841
99. Shaw G.M., Nelson V., Iovannisci D.M., et al. Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies. Am J Epidemiol 157 (2003) 475-484
100. Gordon J.E., and Shy C.M. Agricultural chemical use and congenital cleft lip and/or palate. Arch Environ Health 36 (1981) 213-221
101. García A.M. Occupational exposure to pesticides and congenital malformations: a review of mechanisms, methods, and results. Am J Ind Med 33 (1998) 232-240
102. Dravet C., Julian C., Legras C., et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 42 (1992) 75-82
103. Abrishamchian A.R., Khoury M.J., Calle E.E., et al. The contribution of maternal epilepsy and its treatment to the aetiology of orofacial clefts: a population based case-control study. Genet Epidemiol 11 (1994) 343-351
104. Shaw G.M., Wasserman C.R., O'Malley C.D., Lammer E.J., and Finnell R.H. Orofacial clefts and maternal anticonvulsant use. Reprod Toxicol 9 (1995) 97-98
105. Park-Wyllie L., Mazzotta P., Pastuszak A., et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62 (2000) 385-392
106. Acs N.A., Bánhidy F., Puhó E., and Czeizel A.E. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73 (2005) 989-996
107. Wong F.K., and Hagg U. An update on the aetiology of orofacial clefts. Hong Kong Med J 10 (2004) 331-336
108. Tolarova M.M., and Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet 75 (1998) 126-137
109. Wyszynski D.F., Zeiger J., Tilli M.T., et al. Survey of genetic counsellors and clinical geneticists regarding recurrence risks for families with nonsyndromic cleft lip with or without cleft palate. Am J Med Genet 79 (1998) 184-190
110. Little J., and Bryan E. Congenital anomalies in twins. Semin Perinatol 10 (1986) 50-64
111. Curtis E.J., Fraser F.C., and Warburton D. Congenital cleft lip and palate: risk figures for counseling. Am J Dis Child 102 (1961) 853-857
112. Carter C.O., Evans K., Coffey R., et al. A three generation family study of cleft lip with or without cleft palate. J Med Genet 19 (1982) 246-261
113. Sivertsen A., Wilcox A.J., Skjaerven R., et al. Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives. BMJ 336 (2008) 432-434
114. FitzPatrick D., and Farrall M. An estimation of the number of susceptibility loci for isolated cleft palate. J Craniofac Genet Dev Biol 13 (1993) 230-235
115. Schliekelman P., and Slatkin M. Multiplex relative risk and estimation of the number of loci underlying an inherited disease. Am J Hum Genet 71 (2002) 1369-1385
116. Marazita M.L., Spence M.A., and Melnick M. Major gene determination of liability to cleft lip with or without cleft palate: a multiracial view. J Craniofac Genet Dev Biol Suppl 2 (1986) 89-97
117. Marazita M.L., Hu D.N., Spence M.A., Liu Y.E., and Melnick M. Cleft lip with or without cleft palate in Shanghai, China: evidence for an autosomal major locus. Am J Hum Genet 51 (1992) 648-653
118. Prescott N.J., Lees M.M., Winter R.M., and Malcolm S. Identification of susceptibility loci for nonsyndromic cleft lip with or without cleft palate in a two stage genome scan of affected sib-pairs. Hum Genet 106 (2000) 345-350
119. Zeiger J.S., Hetmanski J.B., Beaty T.H., et al. Evidence for linkage of nonsyndromic cleft lip with or without cleft palate to a region on chromosome 2. Eur J Hum Genet 11 (2003) 835-839
120. Mitchell L.E. Transforming growth factor locus and nonsyndromic cleft lip with or without cleft palate: a reappraisal. Genet Epidemiol 14 (1997) 231-240
121. Zeiger J.S., Beaty T.H., Liang K.Y., et al. Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene environment interaction. Cleft Palate Craniofac J 42 (2005) 58-63
122. Vieira A.R. Association between the transforming growth factor alpha gene and nonsyndromic oral clefts: a HuGE review. Am J Epidemiol 163 (2006) 790-810
123. Chevrier C., Perret C., Bahuau M., et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 143 (2007) 248-257
124. Vieira A.R., Murray J.C., Trembath D., et al. Studies of reduced folate carrier 1 (RFC1) A80G and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects. Am J Med Genet A 135 (2005) 220-223
125. Ioannidis J.P., Bernstein J., Boffetta P., et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol 162 (2005) 302-304
126. Zucchero T.M., Cooper M.E., Maher B.S., et al. Interferon regulatory factor 6 (IRF6) is a modifier for isolated cleft lip and palate. N Engl J Med 351 (2004) 769-780
127. Ghassibe M., Bayet B., Revencu N., et al. Interferon regulatory factor-6: a gene predisposing to isolated cleft lip with or without cleft palate in the Belgian population. Eur J Hum Genet 13 (2005) 1239-1242
128. Park J.W., McIntosh I., Hetmanski J.B., et al. Association between IRF6 and nonsyndromic cleft lip with or without cleft palate in four populations. Genet Med 9 (2007) 219-227
129. Vieira A.R., Cooper M.E., Marazita M.L., Orioli I.M., and Castilla E.E. Interferon regulatory factor 6 (IRF6) is associated with oral-facial cleft in individuals that originate in South America. Am J Med Genet A 143 (2007) 2075-2078
130. Jugessur A., Rahimov F., Lie R.T., et al. Genetic variants in IRF6 and the risk of facial clefts: single-marker and haplotype-based analyses in a population-based case-control study of facial clefts in Norway. Genet Epidemiol 32 (2008) 413-424
131. Dode C., Levilliers J., Dupont J.M., et al. Loss of function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33 (2003) 463-465
132. Celli J., Duijf P., Hamel B.C.J., et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99 (1999) 143-153
133. Barrow L.L., van Bokhoven H., Daack-Hirsch S., et al. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. J Med Genet 39 (2002) 559-566
134. Braybrook C., Doudney K., Marcano A., et al. The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and anykloglossia. Nat Genet 29 (2001) 179-183
135. Kimonis V.E., Goldstein A.M., Pastakia B., et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69 (1997) 299-308
136. Sozen M.A., Suzuki K., Tolarova M.M., et al. Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet 29 (2001) 141-142
137. Fitzpatrick D.R., Carr I.M., McLaren L., et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 12 (2003) 2491-2501
138. Jakobsen L.P., Knudsen M.A., Lespinasse J., et al. The genetic basis of the Pierre Robin Sequence. Cleft Palate Craniofac J 43 (2006) 155-159
139. Birnbaum S., Ludwig K.U., Reutter H., et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet 41 (2009) 473-477
140. Khoury M.J., James L.M., Flanders D., et al. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens. Teratology 46 (1992) 69-77
141. Hwang S.J., Beaty T.H., Panny S.R., et al. Association study of transforming growth factor alpha (TGFa) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 141 (1995) 629-636
142. Shaw G.M., Wasserman C.R., Lammer E.J., et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 58 (1996) 551-561
143. Christensen K., Olsen J., Nørgaard-Pedersen B., et al. Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: a population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 149 (1999) 248-255
144. Shaw G.M., Wasserman C.R., Murray J.C., and Lammer E.J. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J 35 (1998) 366-370
145. Maestri N.E., Beaty T.H., Hetmanski J., et al. Application of transmission disequilibrium tests to nonsyndromic oral clefts: including candidate genes and environmental exposures in the models. Am J Med Genet 73 (1997) 337-344
146. Mitchell L.E., Murray J.C., O'Brien S., and Christensen K. Evaluation of two putative susceptibility loci for oral clefts in the Danish population. Am J Epidemiol 153 (2001) 1007-1015
147. Beaty T.H., Hetmanski J.B., Zeiger J.S., et al. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol 22 (2002) 1-11
148. Hartsfield Jr. J.K., Hickman T.A., Everett E.T., et al. Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. Am J Med Genet 102 (2001) 21-24
149. van Rooij I.A., Wegerif M.J., Roelofs H.M., et al. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: a gene-environment interaction. Epidemiology 12 (2001) 502-507
150. Lammer E.J., Shaw G.M., Iovannisci D.M., et al. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 70 (2004) 846-852
151. van Rooij I.A., Groenen P.M., van Drongelen M., et al. Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. Teratology 66 (2002) 260-266
152. Shaw G.M., Todoroff K., Finnell R.H., et al. Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk. Am J Med Genet 85 (1999) 84-85
153. Jugessur A., Wilcox A.J., Lie R.T., et al. Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol 157 (2003) 1083-1091
154. Chevrier C., Perret C., Bahuau M., et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 143 (2007) 248-257
155. Fryer A.A., and Jones P.W. Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer. IARC Sci Publ 148 (1999) 303-322
156. Shaw W.C., Semb G., Nelson P., et al. The Eurocleft Project 1996-2000: overview. J Craniomaxillofac Surg 29 (2001) 131-140
157. Glenny A.M., Hooper L., Shaw W.C., Reilly S., Kasem S., and Reid J. Feeding interventions for growth and development in infants with cleft lip, cleft palate or cleft lip and palate. Cochrane Database Syst Rev 3 (2004) CD003315.
158. Hasslof P., and Twetman S. Caries prevalence in children with cleft lip and palate: a systematic review of case-control studies. Int J Paediatr Dent 17 (2007) 313-319
159. Stoll C., Dott B., Alembik Y., et al. Evaluation of prenatal diagnosis of cleft/lip palate by foetal ultrasonographic examination. Ann Genet 43 (2000) 11-14
160. Michailidis G.D., Economides D.L., and Schild R.L. The role of three dimensional ultrasound in obstetrics. Curr Opin Obstet Gynecol 13 (2001) 207-214
161. Davalbhakta A., and Hall P.N. The impact of antenatal diagnosis of the effectiveness and timing of counselling for cleft lip and palate. Br J Plast Surg 53 (2000) 298-301
162. Mossey P.A., McColl J., and O'Hara M. Cephalometric features in the parents of children with orofacial clefting. Br J Oral Maxfac Surg 36 (1998) 202-212
163. Sigler A., and Ontiveros D.S. Nasal deformity and microform cleft lip in parents of patients with cleft lip. Cleft Palate Craniofac J 36 (1999) 139-143
164. Woolf C.M., and Gianas A.D. A study of fluctuating dermatoglyphic asymmetry in the sibs and parents of cleft lip propositi. Am J Hum Genet 29 (1977) 503-507
165. Fraser F.C., and Rex A. Excess of parental non-righthandedness in children with right-sided cleft lip: a preliminary report. J Craniofac Genet Dev Biol Suppl 1 (1985) 85-88
166. Sandham A. Cervical vertebral anomalies in cleft lip and palate. Cleft Palate Craniofac J 23 (1986) 206-214
167. Mills L.F., Niswander J.D., Mazaheri M., and Brunelle J.A. Minor oral and facial clefts in relatives of oral cleft patients. Angle Orthod 38 (1968) 199-204
168. Little J., Cardy A., Arslan M.T., Gilmour M., and Mossey P.A. Smoking and orofacial clefts: a United Kingdom-based case-control study. Cleft Palate Craniofac J 41 (2004) 381-386
169. Kaufman N., and Nichter M. The marketing of tobacco to women: global perspectives. In: Samet J.M., and Yoon S.-Y. (Eds). Women and the tobacco epidemic: challenges for the 21st century (2002), World Health Organization, Geneva 69-98
170. Office of the US Surgeon General. Women and smoking: a report of the surgeon General (2001), United States Office of the Surgeon General, Washington
171. Windsor R. Smoking, cessation and pregnancy. In: Samet J.M., and Yoon S.-Y. (Eds). Women and the tobacco epidemic: challenges for the 21st century (2002), World Health Organization, Geneva 147-162
172. Forman D., and Altman D. Vitamins to prevent cancer: supplementary problems. Lancet 364 (2004) 1193-1194